sygnature discovery
PrivateLast Round
Private Equity
Jun 29, 2021
Est. Valuation
$420.7M
Total Funding Raised
$0
Company Overview
The latest recorded funding round for sygnature discovery was a Private Equity round in June 2021. sygnature discovery was founded in 2004.
A world-leading integrated drug discovery and non-clinical solutions provider, offering expertise across a broad range of therapeutic areas and biological target classes.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
sygnature discovery Comparables
Compare sygnature discovery with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| o2h discovery | 84% | |
| IRBM S.p.A. | 83% | |
| Dalriada Drug Discovery | 82% |
For institutional investors. Book with your work email.
sygnature discovery Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Jun 29, 2021 | ||||
| Private Equity | Oct 9, 2017 |
For institutional investors. Book with your work email.
sygnature discovery Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.